Efficacy and safety of parsaclisib-ruxolitinib combination therapy in myelofibrosis patients (Pts) with low vs higher baseline platelet count (PC): A subgroup analysis of data from a phase 2 study Meeting Abstract


Authors: Yacoub, A.; Borate, U.; Rampal, R.; Ali, H.; Wang, E.; Gerds, A.; Hobbs, G.; Kremyanskaya, M.; Winton, E.; O'Connell, C.; Goel, S.; Oh, S.; Schiller, G.; Assad, A.; Erickson-Viitanen, S.; Zhou, F.; Daver, N.
Abstract Title: Efficacy and safety of parsaclisib-ruxolitinib combination therapy in myelofibrosis patients (Pts) with low vs higher baseline platelet count (PC): A subgroup analysis of data from a phase 2 study
Meeting Title: 113th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 82
Issue: 12 Suppl.
Meeting Dates: 2022 Apr 8-13
Meeting Location: New Orleans, LA
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2022-06-15
Language: English
ACCESSION: WOS:000892509500062
PROVIDER: wos
DOI: 10.1158/1538-7445.AM2022-CT541
Notes: Meeting Abstract: CT541 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Raajit Kumar Rampal
    339 Rampal